From Pfizer to Moderna: who’s making billions from Covid-19 vaccines?


The arrival of Covid-19 vaccines promises a return to more normal life - and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies. Here, we look at who is in line for the biggest gains - and which shareholders have already made fortunes.